ArticleFrontiers in public health2026
Prevalence and genotype distribution of human papillomavirus infection among women undergoing HPV testing at a hospital in Zhangzhou, China: a retrospective study.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This retrospective, single-center study aims to analyze the prevalence and genotype distribution of human papillomavirus (HPV) infection in women undergoing HPV testing at a hospital in Zhangzhou, China. Methods: A total of 13,492 females, 18-85 years, undergoing HPV testing at the physical examination center of a hospital in Zhangzhou, China, were recruited. Cervical cast-off cells were collected for HPV testing by low-density gene chip and flow hybridization technology using HPV typing test kit. A total of 27 kinds of HPV types were detected using this method, including 17 kinds of high-risk HPV (HR-HPV) and 10 kinds of low-risk/uncertain oncogenic significance HPV (LR-HPV). Results: The overall HPV infection rate was 16.86% (2,275/13,492), with 12.59% (1,699/13,492) females detected as single HPV-type infection and 4.27% (576/13492) females detected as multiple HPV-type infection. Among all 27 detected HPV types, HPV52 exhibited the highest prevalence (3.58%, 483/13,492), followed by HPV53 (1.76%, 237/13,492) and HPV81 (1.71%, 231/13,492). The most common HPV coinfection pattern was HPV52 + HPV53 (12/2,275). Overall HPV prevalence showed a "two-peak" age-related distribution, with the first peak in the ≤29-year age group (19.69%) and the second peak in the ≥60-year age group (24.45%), respectively. It decreased in the 40- to 49-year age group (13.64%). The prevalence of single/multiple HPV and HR-HPV/LR-HPV infection also exhibited age-related trends similar to those described above. Binary logistic regression analysis revealed a non-linear relationship between HPV prevalence and age ( Conclusion: Our study revealed the basic genotype- and age-specific distribution of HPV infection among females attending the physical examination center of a hospital in Zhangzhou. These results emphasized that the specific population should strengthen regular HPV surveillance and improve awareness of vaccination, especially for the highly prevalent HPV types (HPV52,53,51). In addition, our findings provide valuable insights for the measurement of HPV prevention interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.